News
- Author:
- Susan London
Publish date: February 22, 2013
Major Finding: The 30-day rate of all-cause mortality was 9.9%.
News
- Author:
- Susan London
Publish date: February 21, 2013
Major finding: Among women who had experienced a single pregnancy loss before 20 weeks’ gestation in the past year, those assigned to low-do...
News
- Author:
- Susan London
Publish date: February 13, 2013
Major Finding: Risk-adjusted median all-cause survival did not differ significantly between patients given lungs from donors who smoked heavily an...
News
- Author:
- Susan London
Publish date: February 13, 2013
Major Finding: The 5-year actuarial overall survival was 83%, 69%, and 52% among patients in assay-defined low-, medium-, and high-risk groups, re...
News
- Author:
- Susan London
Publish date: February 4, 2013
Major Finding: Overall, 25 (about 1.7%) of 1,499 breast cancers had activating HER2 mutations. Most of these cancers were HER2 negative by convent...
News
- Author:
- Susan London
Publish date: January 29, 2013
Major Finding: The vaccine was highly immunogenic across dose levels and age groups, and was safe and well tolerated, although local reactions pro...
News
- Author:
- Susan London
Publish date: January 29, 2013
Major Finding: Fully 50% of patients had an error in an antiretroviral regimen or an opportunistic infection medication, and 65% were neither reco...
News
- Author:
- Susan London
Publish date: January 24, 2013
Major Finding: Median progression-free survival was better with pertuzumab than placebo in both the mutant PIK3CA group (12.5 vs. 8.6 months) and ...
News
- Author:
- Susan London
Publish date: January 22, 2013
Major Finding: The false-negative rates of SLN biopsy were 14% for patients who had a chemotherapy-induced downstaging from cN1 to cN0 disease and...
News
- Author:
- Susan London
Publish date: January 22, 2013
Major Finding: When patients were split into three equal groups according to Ki67 cutpoints of low (less than or equal to 15%), intermediate (15.1...
News
- Author:
- Susan London
Publish date: January 21, 2013
Major Finding: Patients with a low vs. high EndoPredict clinical score at 5 years of follow-up were five times as likely to be free of distant met...
News
- Author:
- Susan London
Publish date: December 28, 2012
Major Finding: Colonization among nonimmune children fell to the levels seen among immune children at week 52 after the PCV13 vaccine was introduc...
News
- Author:
- Susan London
Publish date: December 19, 2012
Major Finding: SLN surgery correctly identified axillary nodal status in 91.2% of patients.
News
- Author:
- Susan London
Publish date: December 12, 2012
Major Finding: Eribulin was not significantly better than capecitabine in median overall survival (15.9 vs. 14.5 months, P = .056) or progression-...
News
- Author:
- Susan London
Publish date: December 7, 2012
Major Finding: About 90% of patients had tumors harboring genetic alterations in clinical pathways that could be potentially targeted, such as the...
